US 12,215,330 B2
Wheat with reduced lipoxygenase activity
Ann Slade, Dallas, TX (US); Michelle Noval, Dallas, TX (US); Dayna Loeffler, Dallas, TX (US); Jessica Mullenberg, Dallas, TX (US); and Aaron Holm, Dallas, TX (US)
Assigned to ARCADIA BIOSCIENCES, INC., Dallas, TX (US)
Filed by Arcadia Biosciences, Inc., Dallas, TX (US)
Filed on Dec. 22, 2022, as Appl. No. 18/145,611.
Application 18/145,611 is a continuation of application No. 16/894,187, filed on Jun. 5, 2020, granted, now 11,560,572.
Application 16/894,187 is a continuation of application No. 16/580,975, filed on Sep. 24, 2019, granted, now 10,689,659, issued on Jun. 23, 2020.
Application 16/580,975 is a continuation of application No. 15/994,062, filed on May 31, 2018, granted, now 10,457,951, issued on Oct. 29, 2019.
Application 15/994,062 is a continuation of application No. 15/185,579, filed on Jun. 17, 2016, granted, now 10,087,455, issued on Oct. 2, 2018.
Claims priority of provisional application 62/182,299, filed on Jun. 19, 2015.
Prior Publication US 2023/0212598 A1, Jul. 6, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C12N 15/82 (2006.01); A01H 5/10 (2018.01); A01H 6/46 (2018.01); A23L 7/10 (2016.01); C12N 9/02 (2006.01)
CPC C12N 15/8247 (2013.01) [A01H 5/10 (2013.01); A01H 6/4678 (2018.05); A23L 7/10 (2016.08); A23L 7/198 (2016.08); C12N 9/0069 (2013.01); C12N 15/8243 (2013.01); C12Y 113/11 (2013.01); C12Y 113/11012 (2013.01); A23V 2002/00 (2013.01)] 22 Claims
 
1. A wheat flour comprising a human induced alteration in an Lpx1 gene in a D genome, wherein the wheat flour has a property selected from the group consisting of: (a) increased shelf-life; (b) increased oxidative stability; (c) decreased production of Lpx1 protein; (d) decreased lipoxygenase activity; (e) decreased hexanal production; (f) decreased pinellic acid production; (g) decreased decomposition products from fatty acids; and (h) improved sensory characteristics as compared to flour from a wild type wheat grain.